Results 21 to 30 of about 27,667 (182)

Assessment of a method to detect signals for updating systematic reviews. [PDF]

open access: yes, 2014
BackgroundSystematic reviews are a cornerstone of evidence-based medicine but are useful only if up-to-date. Methods for detecting signals of when a systematic review needs updating have face validity, but no proposed method has had an assessment of ...
Johnsen, Breanne   +3 more
core   +1 more source

Effect of duloxetine on neuropathic pain in patients intolerant to continuous administration of pregabalin

open access: yesSpine Surgery and Related Research, 2017
Purpose: We examined duloxetine's effectiveness in the treatment of neuropathic pain in patients who were intolerant to continuous pregabalin administration.
Yohei Shimada   +17 more
doaj   +1 more source

Pilot study of duloxetine for treatment of aromatase inhibitor‐associated musculoskeletal symptoms [PDF]

open access: yes, 2011
BACKGROUND: Approximately 50% of postmenopausal women with hormone receptor‐positive early stage breast cancer treated with an aromatase inhibitor (AI) develop musculoskeletal symptoms. Standard analgesics are relatively ineffective.
Banerjee, Mousumi   +7 more
core   +1 more source

Future directions for the management of pain in osteoarthritis. [PDF]

open access: yes, 2014
Osteoarthritis (OA) is the predominant form of arthritis worldwide, resulting in a high degree of functional impairment and reduced quality of life owing to chronic pain. To date, there are no treatments that are known to modify disease progression of OA
Aigner T   +23 more
core   +1 more source

Effects of MDMA on body temperature in humans [PDF]

open access: yes, 2014
Hyperthermia is a severe complication associated with the recreational use of 3,4-methylenedioxymethamphetamine(MDMA, Ecstasy). In this review, the clinical laboratory studies that tested the effects of MDMA on body temperature are summarized.
Liechti, Matthias E.
core   +1 more source

Pharmacokinetics of duloxetine self-administered in overdose with quetiapine and other antipsychotic drugs in a Japanese patient admitted to hospital

open access: yesJournal of Pharmaceutical Health Care and Sciences, 2021
Background Combinations of antidepressant duloxetine (at doses of 40–60 mg/day) and other antipsychotics are frequently used in clinical treatment; however, several fatal and nonfatal cases of duloxetine overdose have been documented.
Koichiro Adachi   +4 more
doaj   +1 more source

Possible Role of Cyclic AMP Response Element Binding/Brain-Derived Neurotrophic Factor Signaling Pathway in Mediating the Pharmacological Effects of Duloxetine against Methamphetamine Use-Induced Cognitive Impairment and Withdrawal-Induced Anxiety and Depression in Rats

open access: yesAdvanced Biomedical Research, 2019
Background: Duloxetine is used for treating depression and anxiety. The current study evaluated the effects of duloxetine against methamphetamine withdrawal-induced anxiety, depression, and motor disturbances and methamphetamine use-induced cognitive ...
Sanaz Ramezany Yasuj   +4 more
doaj   +1 more source

Duloxetine reduces pain after Total hip arthroplasty: a prospective, randomized controlled study

open access: yesBMC Musculoskeletal Disorders, 2021
Background Previous studies have demonstrated the efficacy of duloxetine in reducing postoperative pain and opioid consumption. However, the effect of duloxetine on total hip arthroplasty (THA) remains unclear.
Hao Li   +5 more
doaj   +1 more source

The Microglial Activation Inhibitor Minocycline, Used Alone and in Combination with Duloxetine, Attenuates Pain Caused by Oxaliplatin in Mice

open access: yesMolecules, 2021
The antitumor drug, oxaliplatin, induces neuropathic pain, which is resistant to available analgesics, and novel mechanism-based therapies are being evaluated for this debilitating condition.
Kinga Sałat   +2 more
doaj   +1 more source

Use of symptom-relieving drugs before and after surgery for urinary incontinence in women:a cohort study [PDF]

open access: yes, 2013
OBJECTIVE: To describe the use of symptom-relieving drugs (antimuscarinic drugs or duloxetine) before and after surgery for urinary incontinence (UI); and for those with use of antimuscarinic drugs or duloxetine before surgery, to estimate the risk of ...
Brostrøm, Søren   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy